Vaccinex, Inc. (VCNX) SEC Filings — 2024

Filings

• Vaccinex, Inc. Faces Delisting Concerns — 8-K · Dec 17, 2024
• Zauderer Amends VaccinEx Stake Filing — SC 13D/A · Nov 18, 2024
• Vaccinex, Inc. Files 8-K on Material Agreement — 8-K · Nov 14, 2024
• Vaccinex, Inc. SC 13G Filing — SC 13G · Nov 14, 2024
• Vaccinex, Inc. Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
• Vaccinex Faces Delisting Concerns — 8-K · Oct 9, 2024
• Zauderer Amends Vaccinex Stake Filing — SC 13D/A · Sep 20, 2024
• Vaccinex, Inc. Files 8-K: Material Agreement & Equity Sales — 8-K · Sep 19, 2024
• Vaccinex Appoints New CMO, Dr. Wagner Departs — 8-K · Sep 13, 2024
• Vaccinex, Inc. Files 8-K Report — 8-K · Aug 20, 2024
• Vaccinex, Inc. Files 8-K Report — 8-K · Aug 14, 2024
• Vaccinex, Inc. 10-Q: Warrants and Purchase Agreements Detailed — 10-Q · Aug 14, 2024
• Friedberg Group Amends Stake in VaccinEx, Inc. — SC 13D/A · Aug 7, 2024
• Friedberg Group Ups Stake in VaccinEx to 5% — SC 13D/A · Aug 1, 2024
• Vaccinex, Inc. Files 8-K Report — 8-K · Jul 31, 2024
• Vaccinex, Inc. Files 8-K Report — 8-K · Jun 6, 2024
• VACCINEX, INC. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
• Vaccinex, Inc. Files 8-K on Shareholder Vote Matters — 8-K · May 9, 2024
• VACCINEX, INC. Files Amended 10-K for Fiscal Year Ended December 31, 2023 — 10-K/A · Apr 25, 2024
• Vaccinex Faces Delisting Concerns — 8-K · Apr 12, 2024
• Vaccinex, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 2, 2024
• VACCINEX, INC. Files 10-K for Fiscal Year Ended December 31, 2023 — 10-K · Apr 2, 2024
• Vaccinex, Inc. Files 8-K: Material Agreement, Equity Sales, Bylaw Changes — 8-K · Apr 1, 2024
• Vaccinex, Inc. Files 8-K Report — 8-K · Mar 28, 2024
• Vaccinex, Inc. Files 8-K Report — 8-K · Mar 27, 2024
• Vaccinex, Inc. Reports Executive and Director Changes — 8-K · Mar 4, 2024
• Vaccinex Files 8-K for 'Other Events' and Financial Exhibits — 8-K · Feb 21, 2024
• Vaccinex Files 8-K on Security Holder Rights, Bylaw Changes — 8-K · Feb 15, 2024
• Vaccinex Files 8-K for Shareholder Vote Submission — 8-K · Feb 13, 2024
• Vaccinex Insider Maurice Zauderer Updates Stock Ownership — SC 13D/A · Feb 12, 2024
• Point72 Discloses 5.79M Share Stake in Vaccinex (VCNX) — SC 13G · Feb 9, 2024
• Vaccinex Amends 8-K, Confirms Nasdaq Listing for VCNX Common Stock — 8-K/A · Feb 8, 2024
• Vaccinex (VCNX) Reports Unregistered Equity Sales, Material Agreement — 8-K · Feb 7, 2024
• AIGH Capital Management Discloses 9.9% Stake in Vaccinex, Inc. — SC 13G/A · Feb 7, 2024
• Vaccinex, Inc. Announces Special Meeting for Reverse Stock Split Approval — DEF 14A · Jan 8, 2024